Julie Tay Sells 3,500 Shares of Align Technology, Inc. (ALGN) Stock

Align Technology, Inc. (NASDAQ:ALGN) VP Julie Tay sold 3,500 shares of Align Technology stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $253.00, for a total value of $885,500.00. Following the sale, the vice president now directly owns 12,213 shares of the company’s stock, valued at approximately $3,089,889. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Align Technology, Inc. (NASDAQ ALGN) opened at $249.19 on Thursday. The stock has a market capitalization of $20,366.74, a PE ratio of 75.15, a PEG ratio of 2.43 and a beta of 1.42. Align Technology, Inc. has a fifty-two week low of $88.56 and a fifty-two week high of $257.60.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.82 by $0.19. The business had revenue of $385.30 million during the quarter, compared to analysts’ expectations of $359.80 million. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The company’s revenue for the quarter was up 38.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.63 EPS. research analysts anticipate that Align Technology, Inc. will post 3.62 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://sportsperspectives.com/2017/11/16/julie-tay-sells-3500-shares-of-align-technology-inc-algn-stock.html.

Hedge funds have recently modified their holdings of the company. Honkamp Krueger Financial Services Inc. increased its stake in shares of Align Technology by 1.7% in the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 2,037 shares of the medical equipment provider’s stock valued at $306,000 after purchasing an additional 34 shares in the last quarter. Buckingham Asset Management LLC increased its stake in shares of Align Technology by 3.3% in the 2nd quarter. Buckingham Asset Management LLC now owns 1,861 shares of the medical equipment provider’s stock valued at $279,000 after purchasing an additional 59 shares in the last quarter. Security Asset Management increased its stake in shares of Align Technology by 0.5% in the 2nd quarter. Security Asset Management now owns 12,735 shares of the medical equipment provider’s stock valued at $1,912,000 after purchasing an additional 65 shares in the last quarter. BB&T Securities LLC increased its stake in shares of Align Technology by 3.5% in the 2nd quarter. BB&T Securities LLC now owns 2,757 shares of the medical equipment provider’s stock valued at $413,000 after purchasing an additional 94 shares in the last quarter. Finally, Wrapmanager Inc. increased its stake in shares of Align Technology by 2.6% in the 2nd quarter. Wrapmanager Inc. now owns 3,835 shares of the medical equipment provider’s stock valued at $576,000 after purchasing an additional 99 shares in the last quarter. 80.86% of the stock is owned by institutional investors and hedge funds.

A number of analysts have commented on the company. Credit Suisse Group reaffirmed a “positive” rating and set a $261.00 price target (up previously from $209.00) on shares of Align Technology in a research report on Thursday, November 9th. Zacks Investment Research raised Align Technology from a “hold” rating to a “buy” rating and set a $227.00 price target for the company in a research report on Monday, October 30th. Stifel Nicolaus lifted their price target on Align Technology from $205.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, October 23rd. Robert W. Baird reaffirmed a “buy” rating and set a $245.00 price target on shares of Align Technology in a research report on Friday, October 27th. Finally, Leerink Swann reaffirmed an “outperform” rating and set a $250.00 price target on shares of Align Technology in a research report on Friday, October 27th. Eleven investment analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus price target of $219.18.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply